PCN84 COST-EFFECTIVENESS ANALYSES OF DOCETAXEL VERSUS PACLITAXEL ONCE WEEKLY IN PATIENTS WITH METASTATIC BREAST CANCER PROGRESSED AFTER ANTHRACYCLINE CHEMOTHERAPY IN SPAIN
Abstract
Authors
J Corts MA Segu C Frias L Betegn I Oyagez MA Casado